Nature4y
First licensed stem cell therapy for ALS
Its lead product is NeuroNata-R (lenzumestrocel), the world’s first stem cell-based therapy for amyotrophic lateral sclerosis (ALS). NeuroNata-R was approved as an orphan drug for the treatment ...
Kellogg School of Management13y
A Family Fight Against ALS
The cell can’t repair or maintain itself and becomes severely damaged. “This discovery opens up a whole new field for finding an effective treatment ... and ALS that targets the brain, ALS/dementia.
pharmaphorum10d
FDA advisors unconvinced by BrainStorm’s ALS cell therapy
An FDA advisory committee has voted by a huge margin that BrainStorm’s stem cell therapy for amyotrophic lateral sclerosis (ALS) – NurOwn – does not have enough data to support its approval.
pharmaphorum10y
Stem cell therapy for ALS fast-tracked by FDA
A stem cell therapy for amyotophic lateral sclerosis (ALS) could have a shorter route to market after being fast-tracked by the FDA. Israeli firm BrainStorm Cell Therapeutics has been granted the ...
Medpage Today on MSN23d
Novel Agent Safe in ALS, Phase II Study Suggests
Tetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither ... 95% CI 0.84-6.41), ...
Medical News Today25d
What to know about spinal bulbar muscular atrophy (SBMA)
Ongoing research is investigating the use of anti-androgen drugs as a treatment. However, at present, only one drug, known as leuprorelin, has approval for treating SBMA in Japan. Spinal bulbar ...